What was Synlogic’s price range in the past 12 months?
Synlogic lowest share price was $1.47 and its highest was $10.21 in the past 12 months.
What is Synlogic’s market cap?
Currently, no data Available
When is Synlogic’s upcoming earnings report date?
Synlogic’s upcoming earnings report date is May 09, 2024 which is in 13 days.
How were Synlogic’s earnings last quarter?
Synlogic released its earnings results on Mar 19, 2024. The company reported -$1.71 earnings per share for the quarter, missing the consensus estimate of -$0.933 by -$0.777.
What happened to Synlogic’s price movement after its last earnings report?
Synlogic reported an EPS of -$1.71 in its last earnings report, missing expectations of -$0.933. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Synlogic?
Among the largest hedge funds holding Synlogic’s share is RA Capital Management. It holds Synlogic’s shares valued at N/A.
Synlogic, Inc. is a clinical-stage biopharmaceutical company, which engages in drug discovery and development of synthetic biotic medicines. It focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.